Preliminary brief— based on press release only. Full analysis including management tone and Q&A will be added when the transcript is available.

LYB · Q4 2025 Earnings

LyondellBasell

Reported January 30, 2026

30-second summary

FY2025 revenue fell 9.7% to $30.2B and GAAP EPS swung to -$2.34 as the petrochemical trough ground on; full-year EBITDA ex-items printed $2.5B with $362M of free cash flow on 95% cash conversion. The signal isn't the loss — it's the execution: the Cash Improvement Plan delivered $800M in 2025 against a $600M target, and management raised the cumulative target to $1.3B by end-2026 (from $1.1B) with another $500M of incremental cash expected. 2026 capex is confirmed at $1.2B, in line with the indicative figure flagged on the Q3 call. Q1 operating-rate guides are broadly steady versus the prior Q3 quarterly guides — O&P Americas held at ~85%, O&P EAI held at ~75%, and I&D nudged 5pts higher to ~85%. The defensive posture is intact, but the operational delivery — including 95% cash conversion well above the long-term 80% target — is the better-than-expected piece of the print.

Headline numbers

EPS

Q4 FY2025

$1.70

Revenue

Q4 FY2025

$30.15B

-9.7% YoY

Free cash flow

Q4 FY2025

$0.36B

Key financials

Q4 FY2025

Metric	Q4 FY2025	YoY	Q2 FY2025	QoQ
Revenue	$30.15B	-9.7%	$7.66B	+293.7%
EPS	$1.70	—	$0.62	+174.2%
Free cash flow	$0.36B	—	—	—

Guidance

LYB further reduces 2026 CapEx to $1.2B and raises cumulative Cash Improvement Plan target to $1.3B, while guiding to materially lower operating rates across all segments in Q1 FY2026 amid continued market softness.

Guidance is issued for the full year only, refreshed each quarter. Prior and new below are the same FY updated this quarter.

New guidance

Metric	Period	Guide	YoY
Cash Improvement Plan cumulative target	FY 2026	$1.3 billion by end of 2026	—
Additional cash generation from Cash Improvement Plan	FY 2026	$500 million relative to 2025 actuals	—
Olefins & Polyolefins Americas operating rate	Q1 FY2026	approximately 80%	—
Olefins & Polyolefins EAI operating rate	Q1 FY2026	approximately 60%	—
Intermediates & Derivatives operating rate	Q1 FY2026	approximately 75%	—

Changes to prior guidance

Metric	Period	Prior guide	New guide	Δ	Result
Capital expenditures	FY 2026	$1.4 billion	$1.2 billion	-$0.2 billion (-14.3%)	Lowered

Other KPIs

Q4 FY2025

Segment	Q4 FY2025
EBITDA excluding identified items	$2.5 billion
Cash Improvement Plan achievement	$800 million in 2025, exceeding $600 million target
Cash conversion	95%
Operating cash flow	$2.3 billion
Capital expenditures	$1.9 billion
Total liquidity	$8.1 billion
Shareholder returns (dividends and buybacks)	$2.0 billion

Management tone

Narrative arc: Q2 cash preservation pivot → Q3 monitored stabilization → Q4 controlled optimism on operational delivery and capital discipline.

Capacity rationalization remains a structural backdrop, with the European divestiture progressing toward Q2 2026 close. Management continues to frame portfolio optimization and global capacity rationalization as the path back to pricing power, with the divestment of four European assets on track for completion in the second quarter of 2026 per the Q4 release.

Capex has now been reframed permanently as a discipline lever, not a strategic deployment decision. The $1.2B 2026 figure was previewed on the Q3 call as an indicative target ("we could further reduce our capex from $1.4 billion to $1.2 billion again in 2026" — Vanacker, Q3 prior-quarter call) and is now formally confirmed in the Q4 release. MoReTec-1 construction continues; MoReTec-2 and Flex-2 remain in deferred/optional status until market conditions improve.

The dividend defense is now mechanical, not narrative. Q2 framed dividend safety around the cash cushion entering 2025; Q4 frames it around three layers: the start-of-year cash position, balanced capital allocation, and the investment-grade balance sheet as foundational. Stacking three lines of defense — when none individually require comment in good times — is itself the signal.

Cash improvement plan execution is now the primary operational proof point. $800M delivered vs. $600M target, $1.3B cumulative target by end-2026 (raised from $1.1B), and $500M of additional incremental cash relative to 2025 actuals. This is the language management is using to bridge the trough without committing to financial guidance.

Recurring themes management leaned on this quarter:

Early demand inflection signals in polyethylene (PE demand strongest since Q3 2022)Capacity rationalization acceleration as structural supply-side correction (21M tons globally)Cash generation and working capital management as primary value driverGeographic cost-curve bifurcation (low-cost Gulf assets vs. uncompetitive European/Chinese capacity)Portfolio transformation and selective divestiture (European assets sale milestone achieved)Strategic project optionality maintained despite near-term capex discipline

Risks management surfaced:

Trade and tariff policy volatility creating uncertainty in U.S. export flowsNew capacity additions in China still outpacing rationalization in near term (2025-2026)Weak fourth-quarter seasonal demand compressing margins across most segmentsRefinery capacity coming back online in Nigeria potentially pressuring octane cracksPricing power dependent on operating rate improvements and supply-demand rebalancing not yet secured

Answers to last quarter's watch list

H2 2025 operating cash flow recovery against the 80% full-year conversion target — Delivered well above the bar. FY cash conversion came in at 95% with operating cash flow of $2.3B for the full year. The $600M Cash Improvement Plan target was exceeded at $800M. Status: Resolved positively.

Q3 N.A. polyethylene margin expansion — Not directly disclosed in the Q4 print, but full-year EBITDA ex-items of $2.5B against an H1 run-rate suggests H2 segment improvement was modest at best. The cyclical-recovery framing is intact but operating margins did not visibly expand. Status: Continue monitoring.

European asset sale closure timing and proceeds — The Q4 release states the divestment of four European assets is on track for completion in the second quarter of 2026. The SPA was signed at Q3; proceeds have not yet landed in 2025 figures. Status: Pending close.

Dividend coverage trajectory — FY FCF of $362M vs. $2.0B of shareholder returns means dividends were not covered by free cash flow in 2025. The 2026 capex step-down to $1.2B and the $500M incremental CIP cash are designed to close this gap in 2026, but 2025 itself did not. Status: Resolved negatively.

Whether any further capex or project deferrals are announced — 2026 capex formally confirmed at $1.2B, in line with the indicative figure flagged on the Q3 call. MoReTec-1 in Germany continues; MoReTec-2 and Flex-2 remain deferred until conditions improve. Status: Resolved as previewed.

What to watch into next quarter

Whether Q1 actual operating rates come in above the guided 85% / 75% / 85%. Management has historically guided operating rates conservatively when the demand inflection commentary is positive. A beat would confirm the seasonal-improvement framing; an in-line print would imply demand remains range-bound.

Whether FY2026 revenue or EBITDA guidance is initiated on the Q1 call. The continued absence of financial guidance at a year-end print is itself the signal. Re-engagement on FY guidance would be the clearest indicator management sees the trough behind them.

Cash Improvement Plan cumulative trajectory toward $1.3B by end-2026. $800M was delivered in 2025; the $500M incremental for 2026 is the explicit gap. Watch the Q1 update for execution-pace signals — front-loaded delivery would imply the $1.3B target is conservative.

Polyethylene price increase implementation in Q1. Management has flagged tight year-end inventories, winter storm Fern supply reduction, and seasonal demand as supportive for price increases. Whether announced PE increases stick — not just whether they are announced — will determine if the demand commentary translates to margin recovery.

European divestiture close in Q2 2026. The Q4 release flags completion in Q2 2026. Watch for confirmation of timing, final terms, and proceeds flowing through liquidity.

Dividend coverage by organic FCF. 2025 FCF of $362M against ~$1.76B of annual dividends means organic coverage was roughly 21%. The 2026 capex step-down and CIP gains need to push organic FCF materially higher for the dividend math to hold without further portfolio sales.

Whether the MoReTec-2 FID is finally decided or pushed again. Another postponement at the Q1 call would extend the project-deferral arc and signal management is preparing for a longer trough than the demand commentary implies.

Sources

LyondellBasell Q4 2025 press release, SEC filing — https://www.sec.gov/Archives/edgar/data/1489393/000148939326000003/a2025q4exhibit991.htm
LyondellBasell Q3 2025 earnings call transcript — used for prior-quarter context only; all Q4 figures sourced from the Q4 press release.

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.